Hourmant, M <br/><br/>
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.  [electronic resource] 

 -  Transplantation  Jan 1994 
 - 204-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199401001-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Antibodies, Monoclonal--therapeutic use<br/>Antilymphocyte Serum--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--prevention & control<br/>Graft Survival<br/>Humans<br/>Immunosuppression Therapy<br/>Kidney Transplantation--physiology<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Receptors, Interleukin-2--immunology<br/>Reoperation<br/>T-Lymphocytes--immunology